Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Icosavax
2815 Eastlake Ave E, Suite 300
Seattle, WA 98102
http://www.icosavax.com/

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.

Key Contact
Name
Adam Simpson
Title
CEO
Funding Events

Date
Amount
Type
Investors
10/03/19 $51,000,000 Series A Adams Street Partners
NanoDimension
Qiming Venture Partners
Sanofi Ventures
04/07/21 $100,000,000 Series B Adams Street Partners
Cormorant Asset Management
Janus Henderson Investors
ND Capital
Omega Funds
Open Philanthropy Project
Perceptive Advisors
Qiming Venture Partners
RA Capital Management
Sanofi Ventures
Surveyor Capital
Viking Global Investors